Alembic Pharmaceuticals receives USFDA approval for Carbidopa, Levodopa and Entacapone Tablets

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Carbidopa, Levodopa and Entacapone Tablets, 12.5 ...

Alembic Pharmaceuticals gets nod for generic Parkinson's treatment tablets

Alembic Pharmaceuticals Ltd on Friday said it has received approval from the US health regulator for its generic version of ...
Seeking Alpha

Knight Therapeutics Announces Filing of New Drug Submission for CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Canada

CREXONT ® is a novel, oral formulation of carbidopa/levodopa (CD/LD) capsule that combines both immediate-release granules and extended-release beads for the treatment of Parkinson’s disease. CREXONT ...
Rediff Money

Alembic Pharma Gets USFDA Nod for Parkinson's Drug

Alembic Pharmaceuticals receives USFDA approval for generic Carbidopa, Levodopa, and Entacapone tablets to treat Parkinson's ...

Alembic Pharma gets U.S. FDA nod for generic Parkinson’s drug

Alembic Pharmaceuticals has received U.S. Food and Drug Administration final approval for its abbreviated new drug application for Carbidopa, Levodopa and Entacapone Tablets in different strengths.